IPIrina Evgenievna Panova

Irina Evgenievna Panova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irina Evgenievna Panova has a total of 85 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Combined treatment of uveal melanoma: neoadjuvant photodynamic therapy and proton therapy (preliminary results)

    by I. E. Panova, E. V. Boiko, E. V. Samkovich, E. M. Svistunova, N. A. Vorobyev, N. I. Martynova, И. Е. Панова, Э. В. Бойко, Е. В. Самкович, Е. М. Свистунова, et al.

    Aim: to evaluate the efficacy of combined neoadjuvant photodynamic therapy with chlorin e6 and proton therapy for uveal melanoma using ultrasound parameters of intratumor blood flow, densitometric, and morphometric indicators. Material and Methods. A retrospective study included 40 patients (40 eyes) with T2–T4 uveal melanoma. All patients were divided into two groups. Group I (n=19) received proton therapy using pencil beam scanning at a total dose of 49 Gy in 7 fractions. Group II (n=21) received photodynamic therapy with chlorin e6 followed by proton therapy. All patients underwent complex ultrasound examination with color doppler imaging and echodensitometry before treatment and during follow-up. Results. Neoadjuvant photodynamic therapy resulted in earlier and more complete tumor devascularization, showing a much higher number of avascular tumors by the 6th month in group II patients (χ2=12.093; p=0.002). Both groups showed gradual tumor regression and decreased acoustic density, but no statistically significant differences in these parameters between the groups were found. During the first 6 months after treatment, combined treatment resulted in a faster drop in tissue acoustic density measured by echodensitometry than proton therapy alone. Conclusion. Neoadjuvant photodynamic therapy combined with proton therapy produces a pronounced vasculo-occlusive effect that peaks by the 6th month. complex ultrasound examination with color doppler imaging and echodensitometry is an objective tool for assessing tumor regression during organ-preserving treatment.

  • Open Access

    Ultrasonographic Characteristics of Uveal Melanoma Correlated with Histopathological Findings Following Photodynamic Therapy with Chlorin e6

    by Елена Владиславовна Самкович, Ирина Евгеньевна Панова, Эрнест Витальевич Бойко, Сергей Леонидович Воробьев, Елизавета Сергеевна Калашникова, Любовь Алексеевна Инсаркина, Сергей Борисович Шевченко

    Цель. Провести анализ ультразвуковых характеристик увеальной меланомы в сопоставлении с данными морфологического исследования после фотодинамической терапии с хлорином е6. Материалы и методы. В исследование включены 19 пациентов с увеальной меланомой. Больным, которым исходно была показана энуклеация ввиду больших размеров новообразования, из-за отказа от нее в качестве альтернативы первым этапом комбинированного лечения выполнена фотодинамическая терапия (ФДТ) (транссклеральная — одному, гибридная — пяти, транспупиллярная — 13). При отсутствии положительной динамики или при изменении решения пациента вторичная энуклеация выполнена в сроки от 0,25 до 1,5 (0,85 ± 0,49) мес. Для оценки эффективности лечения проводилось комплексное ультразвуковое исследование с цветовым допплеровским картированием (ЦДК) и эходенситометрией. Патоморфологическое исследование меланомы включало оценку морфологического варианта, степени некроза, выявление признаков расстройства кровообращения (тромбов), инвазии в склеру, митотической активности, степени васкуляризации опухоли. Результаты. По данным гистологического анализа, у 14 пациентов опухоль имела веретеноклеточное строение, у двух — эпителиоидноклеточное, у трех — смешанный вариант. Выявлена высокая сопоставимость метрических параметров по данным УЗИ и морфологического исследования (rₛ = 0,89 для высоты, rₛ = 0,91 для диаметра; p < 0,001). Во всех случаях обнаружены некрозы опухолевой ткани, в 17 (89,5 %) — фибринно-эритроцитарные тромбы. Установлены статистически значимые корреляции: между исходной акустической плотностью и степенью некроза (rₛ = –0,59, p = 0,02); между гиперваскулярным типом опухоли по данным ЦДК и наличием выраженной сосудистой сети при морфологическом исследовании (rₛ = 0,56, p = 0,03); между снижением акустической плотности в динамике (с 30,53 ± 1,26 до 25,97 ± 0,83 дБ, Δ –6,56 ± 1,12 дБ) и степенью некроза (rₛ = –0,52, p = 0,04). При транссклеральном и гибридном воздействии зоны некроза локализовались вплотную к склере (0,3–0,5 мм), тромбы — на расстоянии до 6,0 мм от склеры. Выводы. Сопоставление ультразвуковых и морфологических данных показывает, что динамическое снижение акустической плотности и исходный гиперваскулярный характер кровотока являются значимыми предикторами некротических изменений и тромбоза внутриопухолевых сосудов после ФДТ. Полученные результаты обосновывают возможность использования эходенситометрии и допплерографии в качестве объективных критериев ранней оценки ответа на ФДТ.

  • Open Access

    Chlorin e6 as a Photosensitizer for Inducing Targeted Effects in Transscleral Photodynamic Therapy

    by Elena Vladislavovna Samkovich, Ernest Vitalievich Boiko, Irina Evgenievna Panova, Tatyana Georgievna Grishacheva, Sergey Leonidovich Vorobyev, Elizaveta Sergeevna Kalashnikova, Alexander Anatolievich Ivanov, Sergey Borisovich Shevchenko, Viktoria Gievna Gvazava, Elizaveta Antonovna Masian

    Introduction: This study aimed to evaluate the role of chlorin e6 in mediating targeted vascular injury during transscleral photodynamic therapy (TS-PDT) under controlled thermal conditions. Methods: Twenty eyes of ten rabbits were randomized into two groups. The TS-PDT group received intravenous chlorin e6 (2.5 mg/kg) followed by transscleral laser irradiation (660 nm, 0.17 W, 10 min.). The control group (TSLT) underwent identical laser exposure without a photosensitizer. Scleral temperature was monitored in real time using a thermal probe. On day 14, histological analysis assessed choroidal vascular thrombosis and stromal fibrosis using a semiquantitative scoring system. Retinal and scleral tissue damage was also evaluated. Results: The analysis accounting for inter-animal clustering revealed a significant association between chlorin e6 administration and choroidal vascular thrombosis (90% vs. 50%; adjusted OR=9.8, 95% CI: 1.4–68.9; P=0.021) and fibrosis (80% vs. 40%; adjusted OR=6.2, 95% CI: 1.1–35.0; P=0.039). Severity scores for thrombosis and fibrosis were also significantly higher in the TS-PDT group (P<0.001 for both). No significant differences in scleral temperature (P≥0.45) orretinal/scleral damage were observed. Conclusion: Vascular damage during TS-PDT is primarily photochemical, mediated by chlorin e6. No significant intergroupdifferences were observed in monitored scleral surface temperaturesunder these parameters, arguing against a major contribution from differential surface heating. The method demonstrates short-term structuralpreservation of surrounding ocular tissues, supporting itspotential as an organ-preserving treatment for intraocular tumors.

  • Subclinical Progressive Course of Orbital Cholesteatoma. Clinical Case

    by I. E. Panova, M. V. Melikhova, E. M. Svistunova, S. L. Vorobyev

    A clinical case of subclinical orbital cholesteatoma is presented, where disease progression was diagnosed using dynamic magnetic resonance imaging (MRI) over 14 years. Considering the localization of the lesion, a transcutaneous subperiosteal exploratory orbitotomy was performed, involving the complete removal of tumor masses followed by histopathological and immunohistochemical examination of the surgical material. The importance of assessing the tumor’s histopathological characteristics lies in the need for differential diagnosis between cholesteatoma and cholesterol granuloma of the orbit, which significantly impacts prognosis and followup strategies. Given the risk of recurrence, the patient in this case was informed about the necessity of regular check-ups and orbital computed tomography (CT) for monitoring.

  • Results of the anonymous independent Russianlanguage survey of retinologists “SETCHAtochkaRU — 2025”

    by E. V. Bobykin, R. R. Fayzrakhmanov, S. Yu. Golubev, T. I. Dibaev, O. V. Zaytseva, V. N. Kazaikin, E. A. Larina, D. S. Maltsev, N. V. Neroeva, P. A. Nechiporenko, et al.

    Retinology is undoubtedly the avant-garde of modern ophthalmology and develops rapidly. The development and implementation of newest scientific and technological advances in clinical practice contribute to the continuous improvement of diagnostics and various treatments for posterior segment pathologies. At the same time, there are certain national and regional medicine development aspects, as well as controversial issues that can be successfully explored through sociological research, particularly expert surveys. In 2024, we organized and conducted the first independent Russian survey of retinologists, “SETCHAtochkaRU”, aimed at collecting and analyzing data on current practices, opinions, equipment, and challenges in the diagnosis and treatment of vitreoretinal pathology in Russia. The project yielded unique insights and was well received by both respondents and the scientific community. For this reason, we decided to repeat the survey a year later and attempt to make it a regular event, which will allow us to discuss the most modern aspects of retinology and evaluate its development trends. The “SETCHAtochkaRU — 2025” survey involved 430 specialists representing all regions of the Russian Federation, as well as Belarus, Germany, Georgia, Kazakhstan, Kyrgyzstan, Croatia, and Uzbekistan. The updated list of questions included such topical and relevant issues as the perspectives for the artificial intelligence use, antiangiogenic therapy trends (new drugs, biosimilars, regimens, and drug switching strategies), various practical aspects of drug use, laser, and surgical treatment for vitreoretinal pathology, the results of the federal project “Fight Against Diabetes”, and many others. Analysis of the survey results revealed a number of positive trends in the development of Russian ophthalmology. In our opinion, the “SETCHAtochkaRU” project has the potential to develop and improve as an annual monitoring study, generating original evidence base tailored to national specifics.

  • The potential of micropulse cyclophotocoagulation in the management of neovascular glaucoma

    by I.V. Shiryaev, I.E. Panova, M.M. Pravosudova, M.V. Gatsu, A.A. Suetov, S.V. Ankudinova

    Purpose. To evaluate the intraocular pressure (IOP) — lowering efficacy and safety of transscleral micropulse cyclophotocoagulation (mCPC) performed using the domestic laser system ALOD-01 in patients with neovascular glaucoma (NVG). Material and methods. This retrospective study included 38 patients (38 eyes) — 20 men and 18 women — aged 40 to 84 years with II–III stages, non-compensated («b–c») receiving topical hypotensive therapy, previously unoperated NVG, who underwent transscleral mCPC using the ALOD-01 laser system. Safety was evaluated by analyzing intraoperative and postoperative complications, as well as changes in the thickness of the ciliary body pars plicata measured by ultrasound biomicroscopy (UBM). Postoperative dynamics and durability of the hypotensive effect were assessed at 1, 3, 7, 14, and 30 days and at 1, 3, 6, and 12 months. The best corrected visual acuity (BCVA) was assessed after 1, 3, 6, and 12 months. Results. No intraoperative or postoperative complications were observed in any patient. UBM measurements demonstrated no statistically significant changes in ciliary body pars plicata thickness compared with preoperative values. IOP monitoring during the first postoperative month showed the most pronounced hypotensive effect in eyes with an open or partially obstructed anterior chamber angle (ACA); in contrast, eyes with complete organic ACA closure demonstrated subcompensated IOP levels. The proportion of eyes achieving an IOP reduction of ≥30% from baseline was 29% at day 1, 37% at day 7, 39% at days 14 and 21, and 53% at day 30 (p< 0.05). In the long term, all patients with an open ACA maintained stable IOP levels for 12 months without additional surgical intervention. In the partially closed ACA group, repeat mCPC sessions were required. Sustained IOP control and a reduction in the number of hypotensive medications were achieved by month 9 and remained stable at 12 months. In the closed ACA group, repeat mCPC was performed in four medically fragile patients; drainage surgery was performed in 18 patients, and four patients required additional laser sessions after surgery. In all cases, laser and surgical treatments were administered in conjunction with topical hypotensive therapy and resulted in IOP reduction to target levels within 9–12 months. The dynamics of BCVA, depending on the condition of the ACA, did not show statistically significant differences in indicators during the entire follow-up period. Conclusion. Transscleral mCPC performed with the ALOD-01 laser system, in combination with topical hypotensive therapy, results in a significant reduction of IOP in patients with decompensated NVG and, in selected cases, may be considered a preparatory step prior to dr ainage device implantation. Keywords: neovascular glaucoma, micropulse cyclophotocoagulation, drainage devices, intraocular pressure

  • Ciliary body medulloepithelioma associated with fungal endophthalmitis (clinical observation)

    by I.E. Panova, E.V. Samkovich, A.A. Pimenova, S.L. Vorobyev

    This article presents two clinical cases of medulloepithelioma of the nonpigmented epithelium of the ciliary body, an extremely rare congenital intraocular tumor that may follow either a benign or malignant course. In the presented cases, late disease manifestation was observed in the presence of similar medical histories and comparable clinical and instrumental findings; in both cases, histopathological examination revealed fungal flora. The article also discusses epidemiological aspects, clinical manifestations, and morphological features of this pathological condition, aiming to improve early diagnosis and enable organ-preserving treatment.

  • Open Access

    Radiation Therapy Complications in Choroidal Melanoma and Strategies for Their Management

    by E. M. Svistunova, I. A. Al-Mousa, L. A. Insarkina, A. A. Bykhovsky, I. E. Panova

    Introduction . Organ-preserving modalities are the current standard of care in the management of choroidal melanoma (CM), with radiation therapy playing a pivotal role. Despite its high efficacy, radiation exposure is associated with a broad spectrum of post-radiation complications, which may compromise treatment outcomes and, in some cases, necessitate secondary enucleation. The objective of the work is to summarize current evidence on the use of radiation therapy in CM, analyze the range and incidence of post-radiation complications, identify associated risk factors, and evaluate strategies for prevention and management depending on the treatment modality. Materials and methods . A literature search and analysis of scientific publications in Russian and English was conducted using relevant keywords. Inclusion criteria: original studies (randomized and non-randomized clinical trials), reviews (meta-analyses and systematic reviews) relevant to the topic. Results and discussion . This review encompasses modern methods of radiation therapy for CM, including brachytherapy, proton beam therapy, and stereotactic radiosurgery, with attention to their indications and clinical efficacy. The types, frequency, and specific features of post-radiation complications are analyzed, including damage to the eyelid and periocular skin, cornea, lens, macula, optic nerve, secondary glaucoma, among others. Risk factors for such complications are discussed, along with available preventive and therapeutic approaches. Conclusion . Although different radiation modalities for CM share a similar spectrum of complications, their frequency and predominance vary considerably depending on the chosen technique. Most complications are manageable; however, neovascular glaucoma, scleromalacia, and persistent trophic corneal ulcers may require secondary enucleation. These outcomes highlight the need for improved prevention, early detection of complications, and clear patient selection criteria for organ-preserving treatment of choroidal melanoma.

  • Open Access

    Local Radiation Complications Following Proton Therapy for Uveal Melanoma

    by I. E. Panova, E. M. Svistunova, N. A. Vorobyev, N. I. Martynova, I. A.I. Al-Mousa

    Purpose: to study the frequency and clinical symptoms of local radiation complications that occur after proton therapy in patients with uveal melanoma using pencil beam scanning technology. Patients and methods: The retrospective analysis included 35 patients with uveal melanoma who received proton therapy using pencil beam scanning technology in hypofractionation mode at a dose of 49 Gy in 7 fractions. The initial tumor prominence was 9.2 mm (Me 9.7; IQR 2.75), the base diameter was 16.1 mm (Me 16.5; IQR 11.25), and the follow-up period was 3 to 54 months (Me 13.0; IQR 9.5 months). Results. In the study group, sustained local tumor control was achieved in all patients, and complete tumor regression was observed in 3 patients in 22–26 months after the start of treatment. With a median follow-up of 13.0 months, a wide range of various radiation-related complications was observed, with the most common being ophthalmic hypertension (54.3 %), cataract (51.4 %), and neovascular glaucoma (34.3 %). In addition, dermatitis (34.4 %), dry eye syndrome (17.1 %), post-radiation retinopathy (14.3 %), hemophthalmus (8.6 %), and scleromaly (2.9 %) were recorded at various times. Secondary enucleation was performed in 6 (17.1 %) of the treated patients due to the development of secondary neovascular glaucoma or corneal ulcer with a risk of perforation. Conclusion. Proton therapy with a scanning pencil beam in hypofractionation mode in the treatment of UM is characterized by the same effectiveness of the local effect on the tumor and the range and frequency of post-radiation complications as the literature data. Not only the improvement of technology, the development of preventive measures, but also the definition of clear criteria for indications and limitations for the use of this treatment method are required to reduce the risk of developing post-radiation damage.

  • Open Access

    Transscleral Photodynamic Therapy with a Chlorin e6 Photosensitizer in a Rabbit Experimental Model of an Intraocular Mass Lesion

    by Ernest V. Boiko, Elena V. Samkovich, Irina E. Panova, Sergey B. Shevchenko, Sergey L. Vorobyev, Elizaveta S. Kalashnikova, Elizaveta A. Masian, Victoria G. Gvazava

    Introduction: In vivo modeling of intraocular neoplasms remains challenging due to the limitations of conventional methods, such as the poor viability of xenografted B16 melanoma cells, the need for immunosuppression, and discrepancies between histopathological features and those of human uveal melanoma. Developing a biologically relevant, reproducible model for transscleral photodynamic therapy (TS-PDT) using chlorin-based photosensitizers is essential, particularly to assess radiation penetration depth and the safety profile of the method. Methods: A model of an intraocular mass was created using an alloplant—an acellular biomaterial derived from the kidney capsule—implanted into the suprachoroidal space of rabbit eyes in both pigmented and non-pigmented variants. TS-PDT was performed using chlorin e6 (2.5 mg/kg) and a 660 nm laser (0.17 W, 10 minutes). Monitoring included ultrasound imaging, fundus photography, and histological analysis conducted 41 days post-treatment. Results: The alloplant maintained structural integrity and elicited only minimal inflammatory response. The absence of thermal damage to the sclera confirmed the safety of the selected treatment parameters. In the choroid, focal thrombosis, vascular ectasia, and stromal fibrosis were observed. Retinal necrosis overlying the alloplant (penetration depth>3 mm) indicated sufficient radiation penetration. The pigmented model demonstrated accumulations of pigment-laden macrophages, replicating the optical properties of melanin-containing tissues. Conclusion: This alloplant-based model enables standardized TS-PDT investigation with clinical relevance and confirmed safety. The selective effect on deep ocular tissues supports TS-PDT’s potential in eye-preserving tumor therapy. Future directions include studying neovascularization and optimizing treatment protocols.